These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9921708)
1. Nefazodone for mood disorder associated with epilepsy. Balon R J Clin Psychiatry; 1998 Dec; 59(12):690. PubMed ID: 9921708 [No Abstract] [Full Text] [Related]
2. Response to nefazodone in a depressed patient with end-stage renal disease. Seabolt JL; De León OA Gen Hosp Psychiatry; 2001; 23(1):45-6. PubMed ID: 11291641 [No Abstract] [Full Text] [Related]
4. An open-label trial of nefazodone in high comorbidity panic disorder. DeMartinis NA; Schweizer E; Rickels K J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561 [TBL] [Abstract][Full Text] [Related]
5. Treatment of depressed methadone maintenance patients with nefazodone. A case series. Hamilton SP; Klimchak C; Nunes EV Am J Addict; 1998; 7(4):309-12. PubMed ID: 9809136 [TBL] [Abstract][Full Text] [Related]
7. Clinical use of nefazodone in major depression: a 6-year perspective. Schatzberg AF; Prather MR; Keller MB; Rush AJ; Laird LK; Wright CW J Clin Psychiatry; 2002; 63 Suppl 1():18-31. PubMed ID: 11890561 [No Abstract] [Full Text] [Related]
8. Nefazodone-breakthrough therapy for depressive disorders with sexual dysfunction. Ir Med J; 1996; 89(5):190. PubMed ID: 8936847 [No Abstract] [Full Text] [Related]
9. [Nefazodone: a new antidepressive agent. Advantages of a dual working principle]. Nervenarzt; 1997 Jul; 68(7 Suppl Neues Anti):1-4. PubMed ID: 9431359 [No Abstract] [Full Text] [Related]
10. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial. Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611 [TBL] [Abstract][Full Text] [Related]
11. Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent. Campo JV; Smith C; Perel JM Arch Gen Psychiatry; 1998 Nov; 55(11):1050-2. PubMed ID: 9819077 [No Abstract] [Full Text] [Related]
12. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression. Feighner J; Targum SD; Bennett ME; Roberts DL; Kensler TT; D'Amico MF; Hardy SA J Clin Psychiatry; 1998 May; 59(5):246-53. PubMed ID: 9632036 [TBL] [Abstract][Full Text] [Related]
14. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings. Zajecka JM J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357 [TBL] [Abstract][Full Text] [Related]
16. Nefazodone, psychotherapy, and their combination for chronic depression. Rubin RT N Engl J Med; 2000 Oct; 343(14):1041; author reply 1042-3. PubMed ID: 11023391 [No Abstract] [Full Text] [Related]
17. Curvaceous model of recovery from depression. Livingston MG; Clark A Lancet; 1997 Feb; 349(9050):447. PubMed ID: 9040570 [No Abstract] [Full Text] [Related]